Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 561

1.

Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.

Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust TÅ, Tervonen H, Thursfield V, Ransom D, Shack L, Woods RR, Turner D, Leonfellner S, Ryan S, Saint-Jacques N, De P, McClure C, Ramanakumar AV, Stuart-Panko H, Engholm G, Walsh PM, Jackson C, Vernon S, Morgan E, Gavin A, Morrison DS, Huws DW, Porter G, Butler J, Bryant H, Currow DC, Hiom S, Parkin DM, Sasieni P, Lambert PC, Møller B, Soerjomataram I, Bray F.

Lancet Oncol. 2019 Sep 11. pii: S1470-2045(19)30456-5. doi: 10.1016/S1470-2045(19)30456-5. [Epub ahead of print]

2.

Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial.

Hardy JR, Skerman H, Philip J, Good P, Currow DC, Mitchell G, Yates P.

BMJ Open. 2019 Sep 12;9(9):e029942. doi: 10.1136/bmjopen-2019-029942.

3.

Mental wellbeing in bereaved carers: A Health Survey for England population study.

Hodiamont F, Allgar V, Currow DC, Johnson MJ.

BMJ Support Palliat Care. 2019 Sep 6. pii: bmjspcare-2019-001957. doi: 10.1136/bmjspcare-2019-001957. [Epub ahead of print]

PMID:
31492672
4.

The Association between Glycemic Control in People with Diabetes and Symptoms at the End of Life: A Prospective Observational Consecutive Cohort Study.

Kleinig PA, Woodman RJ, Currow DC.

J Palliat Med. 2019 Aug 13. doi: 10.1089/jpm.2019.0083. [Epub ahead of print]

PMID:
31408400
5.

A Randomized, Double-Blind, Multisite, Pilot, Placebo-Controlled Trial of Regular, Low-Dose Morphine on Outcomes of Pulmonary Rehabilitation in COPD.

Kochovska S, Fazekas B, Hensley M, Wheatley J, Allcroft P, Currow DC.

J Pain Symptom Manage. 2019 Aug 9. pii: S0885-3924(19)30440-3. doi: 10.1016/j.jpainsymman.2019.07.026. [Epub ahead of print] No abstract available.

PMID:
31404644
6.

Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial.

Johnson MJ, Cockayne S, Currow DC, Bell K, Hicks K, Fairhurst C, Gabe R, Torgerson D, Jefferson L, Oxberry S, Ghosh J, Hogg KJ, Murphy J, Allgar V, Cleland JGF, Clark AL.

ESC Heart Fail. 2019 Aug 6. doi: 10.1002/ehf2.12498. [Epub ahead of print]

7.

Palliative Care for people living with heart failure - European Association for Palliative Care Task Force expert position statement.

Sobanski PZ, Alt-Epping B, Currow DC, Goodlin SJ, Grodzicki T, Hogg K, Janssen DJA, Johnson MJ, Krajnik M, Leget C, Martínez-Sellés M, Moroni M, Mueller PS, Ryder M, Simon ST, Stowe E, Larkin PJ.

Cardiovasc Res. 2019 Aug 6. pii: cvz200. doi: 10.1093/cvr/cvz200. [Epub ahead of print]

PMID:
31386104
8.

Cancer screening in Australia: successes, challenges and future directions.

Aranda S, Currow DC.

Public Health Res Pract. 2019 Jul 31;29(2). pii: 2921909. doi: 10.17061/phrp2921909. No abstract available.

9.

Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast Metastases.

Yee J, Davis GM, Hackett D, Beith JM, Wilcken N, Currow D, Emery J, Phillips J, Martin A, Hui R, Harrison M, Segelov E, Kilbreath SL.

J Pain Symptom Manage. 2019 Jul 30. pii: S0885-3924(19)30435-X. doi: 10.1016/j.jpainsymman.2019.07.022. [Epub ahead of print]

PMID:
31374368
10.

Use of time in people with a life-limiting illness: A longitudinal cohort feasibility pilot study.

Jones TA, Olds TS, Currow DC, Williams MT.

Palliat Med. 2019 Aug 1:269216319867214. doi: 10.1177/0269216319867214. [Epub ahead of print]

PMID:
31368843
11.

Australia-modified Karnofsky Performance Scale and physical activity in COPD and lung cancer: an exploratory pooled data analysis.

Barbetta C, Allgar V, Maddocks M, Ribeiro C, Wilcock A, Currow DC, Phillips J, Johnson MJ.

BMJ Support Palliat Care. 2019 Jul 11. pii: bmjspcare-2019-001869. doi: 10.1136/bmjspcare-2019-001869. [Epub ahead of print]

PMID:
31296518
12.

Renewed cervical screening: what the early results tell us.

Currow DC, Aranda S.

Med J Aust. 2019 Aug;211(3):110-111. doi: 10.5694/mja2.50267. Epub 2019 Jul 8. No abstract available.

PMID:
31282590
13.

Clustering of 27,525,663 Death Records from the United States Based on Health Conditions Associated with Death: An Example of big Health Data Exploration.

Janssen DJA, Rechberger S, Wouters EFM, Schols JMGA, Johnson MJ, Currow DC, Curtis JR, Spruit MA.

J Clin Med. 2019 Jun 27;8(7). pii: E922. doi: 10.3390/jcm8070922.

14.

End-of-life care for patients with advanced lung cancer and chronic obstructive pulmonary disease. Authors' reply.

Krajnik M, Currow DC, Brożek B, Damps-Konstańska I, Pierzchała W, Barczyk A, Jassem E.

Pol Arch Intern Med. 2019 Jun 28;129(6):436-437. doi: 10.20452/pamw.14886. Epub 2019 Jun 28. No abstract available.

15.

Risk of emergency hospitalisation and survival outcomes following adjuvant chemotherapy for early breast cancer in New South Wales, Australia.

Tervonen HE, Chen TYT, Lin E, Boyle FM, Moylan EJ, Della-Fiorentina SA, Beith J, Johnston A, Currow DC.

Eur J Cancer Care (Engl). 2019 Jun 21:e13125. doi: 10.1111/ecc.13125. [Epub ahead of print]

PMID:
31222826
16.

Oxygen use in chronic heart failure to relieve breathlessness: A systematic review.

Asano R, Mathai SC, Macdonald PS, Newton PJ, Currow DC, Phillips J, Yeung WF, Davidson PM.

Heart Fail Rev. 2019 Jun 19. doi: 10.1007/s10741-019-09814-0. [Epub ahead of print] Review.

PMID:
31222538
17.

A Response to: Challenges in Recruiting Patients to a Controlled Feasibility Study of a Drug for Opioid-Induced Constipation: Lessons From the Population With Advanced Cancer.

Clark K, Allingham S, Phillips JL, Brown L, Currow DC.

J Pain Symptom Manage. 2019 Sep;58(3):e1-e2. doi: 10.1016/j.jpainsymman.2019.04.037. Epub 2019 May 22. No abstract available.

PMID:
31128231
18.

Harms From Haloperidol for Symptom Management in Palliative Care-a Post Hoc Pooled Analysis of Three Randomized Controlled Studies and Two Consecutive Cohort Studies.

Matsuoka H, Agar M, Vandersman Z, Good P, Fazekas B, Brown L, Hardy J, Weil J, Currow DC.

J Pain Symptom Manage. 2019 Sep;58(3):e6-e8. doi: 10.1016/j.jpainsymman.2019.05.004. Epub 2019 May 20. No abstract available.

PMID:
31121249
19.

A perfect storm: fear of litigation for end of life care.

Mitchell GK, Willmott L, White BP, Piper D, Currow DC, Yates PM.

Med J Aust. 2019 Jun;210(10):441-441.e1. doi: 10.5694/mja2.50164. Epub 2019 May 8. No abstract available.

PMID:
31069804
20.

Battery operated fan and chronic breathlessness: does it help?

Barnes-Harris M, Allgar V, Booth S, Currow D, Hart S, Phillips J, Swan F, Johnson MJ.

BMJ Support Palliat Care. 2019 May 8. pii: bmjspcare-2018-001749. doi: 10.1136/bmjspcare-2018-001749. [Epub ahead of print]

PMID:
31068332
21.

Safety and outcomes of 177 Lu-DOTATATE for neuroendocrine tumours: Experience in New South Wales, Australia.

Lin E, Chen T, Little A, Holliday L, Roach P, Butler P, Hosking E, Bailey E, Elison B, Currow D.

Intern Med J. 2019 May 6. doi: 10.1111/imj.14336. [Epub ahead of print]

PMID:
31062490
22.

Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7).

King MT, Agar M, Currow DC, Hardy J, Fazekas B, McCaffrey N.

Support Care Cancer. 2019 Apr 16. doi: 10.1007/s00520-019-04754-9. [Epub ahead of print]

PMID:
30993452
23.

Relating Experienced To Recalled breathlessness Observational (RETRO) study: a prospective study using a mobile phone application.

Sandberg J, Lansing R, Anderberg P, Currow D, Sundh J, Ahmadi Z, Palmqvist S, Ekström M.

BMJ Open Respir Res. 2019 Feb 12;6(1):e000370. doi: 10.1136/bmjresp-2018-000370. eCollection 2019.

24.

Differences in cancer incidence by age at diagnosis between Aboriginal and non-Aboriginal people for cancer types included in Australian national screening programs.

Tervonen HE, Morrell S, Roder D, You H, Currow DC.

Cancer Epidemiol. 2019 Jun;60:102-105. doi: 10.1016/j.canep.2019.03.012. Epub 2019 Mar 30.

PMID:
30933888
25.

The trajectory of functional decline over the last 4 months of life in a palliative care population: A prospective, consecutive cohort study.

Morgan DD, Tieman JJ, Allingham SF, Ekström MP, Connolly A, Currow DC.

Palliat Med. 2019 Jun;33(6):693-703. doi: 10.1177/0269216319839024. Epub 2019 Mar 27.

PMID:
30916620
26.

How Can Activity Monitors Be Used in Palliative Care Patients?

To THM, Currow DC, Swetenham K, Morgan DD, Tieman J.

J Palliat Med. 2019 Jul;22(7):830-832. doi: 10.1089/jpm.2018.0414. Epub 2019 Mar 19.

PMID:
30888890
27.

End-of-life care for patients with advanced lung cancer and chronic obstructive pulmonary disease: survey among Polish pulmonologists.

Brożek B, Damps-Konstańska I, Pierzchała W, Barczyk A, Currow DC, Jassem E, Krajnik M.

Pol Arch Intern Med. 2019 Apr 30;129(4):242-252. doi: 10.20452/pamw.4478. Epub 2019 Mar 5.

28.

REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol.

Sundh J, Bornefalk-Hermansson A, Ahmadi Z, Blomberg A, Janson C, Currow DC, McDonald CF, McCaffrey N, Ekström M.

BMC Pulm Med. 2019 Feb 26;19(1):50. doi: 10.1186/s12890-019-0809-7.

29.

Timely recognition of palliative care needs of patients with advanced chronic heart failure: a pilot study of a Dutch translation of the Needs Assessment Tool: Progressive Disease - Heart Failure (NAT:PD-HF).

Janssen DJ, Boyne J, Currow DC, Schols JM, Johnson MJ, La Rocca HB.

Eur J Cardiovasc Nurs. 2019 Jun;18(5):375-388. doi: 10.1177/1474515119831510. Epub 2019 Feb 13.

PMID:
30760021
30.

Approaches to palliative oxygen therapy in chronic obstructive pulmonary disease: a multi-national survey of specialists.

Smallwood N, Currow D, Booth S, Spathis A, Irving L, Philip J.

Intern Med J. 2019 Feb;49(2):252-256. doi: 10.1111/imj.14195.

PMID:
30754086
31.

Pathways to diagnosis of non-small cell lung cancer: a descriptive cohort study.

Purdie S, Creighton N, White KM, Baker D, Ewald D, Lee CK, Lyon A, Man J, Michail D, Miller AA, Tan L, Currow D, Young JM.

NPJ Prim Care Respir Med. 2019 Feb 8;29(1):2. doi: 10.1038/s41533-018-0113-7.

32.

Oral dexamethasone in the management of cancer-related pain: A feasibility study.

Eastman P, Currow DC, Fazekas B, Brown L, Le B.

Palliat Med. 2019 Apr;33(4):477-478. doi: 10.1177/0269216319827802. Epub 2019 Feb 4. No abstract available.

PMID:
30712474
33.

Acute-on-Chronic Breathlessness: Recognition and Response.

Hutchinson A, Johnson MJ, Currow D.

J Pain Symptom Manage. 2019 May;57(5):e4-e5. doi: 10.1016/j.jpainsymman.2019.01.012. Epub 2019 Jan 31. No abstract available.

PMID:
30710626
34.

Cognitive screening in chronic obstructive pulmonary disease: patient's perspectives.

Disler RT, Spiliopoulos N, Inglis SC, Currow DC, Davidson PM.

Disabil Rehabil. 2019 Jan 26:1-7. doi: 10.1080/09638288.2018.1519046. [Epub ahead of print]

PMID:
30686080
35.

Sertraline or placebo in chronic breathlessness? Lessons from placebo research.

Currow DC, Agar M, Ekström M.

Eur Respir J. 2019 Jan 17;53(1). pii: 1802316. doi: 10.1183/13993003.02316-2018. Print 2019 Jan. No abstract available.

PMID:
30655452
36.

Agreement Between Breathlessness Severity and Unpleasantness in People With Chronic Breathlessness: A Longitudinal Clinical Study.

Ekström M, Williams M, Johnson MJ, Huang C, Currow DC.

J Pain Symptom Manage. 2019 Apr;57(4):715-723.e5. doi: 10.1016/j.jpainsymman.2019.01.001. Epub 2019 Jan 10.

PMID:
30639756
37.
38.

Validated screening tools for the assessment of cachexia, sarcopenia, and malnutrition: a systematic review.

Miller J, Wells L, Nwulu U, Currow D, Johnson MJ, Skipworth RJE.

Am J Clin Nutr. 2018 Dec 1;108(6):1196-1208. doi: 10.1093/ajcn/nqy244.

PMID:
30541096
39.

Combating escalating harms associated with pharmaceutical opioid use in Australia: the POPPY II study protocol.

Gisev N, Pearson SA, Dobbins T, Currow DC, Blyth F, Larney S, Dunlop A, Mattick RP, Wilson A, Degenhardt L.

BMJ Open. 2018 Dec 4;8(12):e025840. doi: 10.1136/bmjopen-2018-025840.

40.

Statistical compared to clinical significance and the risk of misattribution.

Ekström M, Johnson MJ, Currow DC.

Eur Respir J. 2018 Nov 29;52(5). pii: 1801723. doi: 10.1183/13993003.01723-2018. Print 2018 Nov. No abstract available.

PMID:
30498053
41.

Response to "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later".

Boland JW, Currow D, Johnson M.

J Pain Symptom Manage. 2019 Mar;57(3):e12-e13. doi: 10.1016/j.jpainsymman.2018.11.018. Epub 2018 Nov 26. No abstract available.

PMID:
30496789
42.

Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia-Review and Expert Opinion.

Currow DC, Maddocks M, Cella D, Muscaritoli M.

Int J Mol Sci. 2018 Nov 5;19(11). pii: E3471. doi: 10.3390/ijms19113471. Review.

43.

Older Patients' Perspectives of Online Health Approaches in Chronic Obstructive Pulmonary Disease.

Disler RT, Inglis SC, Newton P, Currow DC, Macdonald PS, Glanville AR, Donesky D, Carrieri-Kohlman V, Davidson PM.

Telemed J E Health. 2019 Sep;25(9):840-846. doi: 10.1089/tmj.2018.0098. Epub 2018 Nov 5.

PMID:
30394859
44.

Letter to the Editor Re: "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later".

Clark K, Sheehan C, Currow DC.

J Pain Symptom Manage. 2019 Jan;57(1):e16-e17. doi: 10.1016/j.jpainsymman.2018.10.498. Epub 2018 Oct 25. No abstract available.

PMID:
30367928
45.

Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial.

Currow DC, Ekström M, Louw S, Hill J, Fazekas B, Clark K, Davidson PM, McDonald C, Sajkov D, McCaffrey N, Doogue M, Abernethy AP, Agar M.

Eur Respir J. 2019 Jan 17;53(1). pii: 1801270. doi: 10.1183/13993003.01270-2018. Print 2019 Jan.

PMID:
30361250
46.

Integration of oncology and palliative care: a Lancet Oncology Commission.

Kaasa S, Loge JH, Aapro M, Albreht T, Anderson R, Bruera E, Brunelli C, Caraceni A, Cervantes A, Currow DC, Deliens L, Fallon M, Gómez-Batiste X, Grotmol KS, Hannon B, Haugen DF, Higginson IJ, Hjermstad MJ, Hui D, Jordan K, Kurita GP, Larkin PJ, Miccinesi G, Nauck F, Pribakovic R, Rodin G, Sjøgren P, Stone P, Zimmermann C, Lundeby T.

Lancet Oncol. 2018 Nov;19(11):e588-e653. doi: 10.1016/S1470-2045(18)30415-7. Epub 2018 Oct 18. Review.

PMID:
30344075
47.

Attitudes to specialist palliative care and advance care planning in people with COPD: a multi-national survey of palliative and respiratory medicine specialists.

Smallwood N, Currow D, Booth S, Spathis A, Irving L, Philip J.

BMC Palliat Care. 2018 Oct 15;17(1):115. doi: 10.1186/s12904-018-0371-8.

48.

Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study.

Bajwah S, Davies JM, Tanash H, Currow DC, Oluyase AO, Ekström M.

Eur Respir J. 2018 Dec 6;52(6). pii: 1801278. doi: 10.1183/13993003.01278-2018. Print 2018 Dec.

PMID:
30309973
49.

Providing Palliative Care at the End of Life: Should Health Professionals Fear Regulation?

Willmott L, White B, Piper D, Yates P, Mitchell G, Currow D.

J Law Med. 2018 Oct;26(1):214-245.

PMID:
30302984
50.

Stigma and the in(visible) perspectives and expectations of home oxygen therapy among people with chronic breathlessness syndrome: A qualitative study.

Breaden K, Collier A, Litster C, Allcroft P, Currow DC, Phillips JL.

Palliat Med. 2019 Jan;33(1):82-90. doi: 10.1177/0269216318805621. Epub 2018 Oct 9. No abstract available.

PMID:
30296930

Supplemental Content

Loading ...
Support Center